Logo image of HELE

HELEN OF TROY LTD (HELE) Stock Fundamental Analysis

USA - NASDAQ:HELE - BMG4388N1065 - Common Stock

19.87 USD
+0.14 (+0.71%)
Last: 10/16/2025, 5:53:28 PM
19.51 USD
-0.36 (-1.81%)
After Hours: 10/16/2025, 5:53:28 PM
Fundamental Rating

3

Overall HELE gets a fundamental rating of 3 out of 10. We evaluated HELE against 63 industry peers in the Household Durables industry. While HELE is still in line with the averages on profitability rating, there are concerns on its financial health. HELE is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HELE had positive earnings in the past year.
HELE had a positive operating cash flow in the past year.
Each year in the past 5 years HELE has been profitable.
In the past 5 years HELE always reported a positive cash flow from operatings.
HELE Yearly Net Income VS EBIT VS OCF VS FCFHELE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

HELE has a Return On Assets of -27.37%. This is amonst the worse of the industry: HELE underperforms 90.48% of its industry peers.
The Return On Equity of HELE (-71.13%) is worse than 90.48% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.34%, HELE is in line with its industry, outperforming 52.38% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HELE is below the industry average of 10.32%.
Industry RankSector Rank
ROA -27.37%
ROE -71.13%
ROIC 7.34%
ROA(3y)4.94%
ROA(5y)6.79%
ROE(3y)9.09%
ROE(5y)12.93%
ROIC(3y)7.78%
ROIC(5y)9.49%
HELE Yearly ROA, ROE, ROICHELE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of HELE has declined.
HELE's Operating Margin of 9.29% is in line compared to the rest of the industry. HELE outperforms 58.73% of its industry peers.
In the last couple of years the Operating Margin of HELE has declined.
HELE's Gross Margin of 47.30% is amongst the best of the industry. HELE outperforms 88.89% of its industry peers.
In the last couple of years the Gross Margin of HELE has grown nicely.
Industry RankSector Rank
OM 9.29%
PM (TTM) N/A
GM 47.3%
OM growth 3Y-3.04%
OM growth 5Y-2.95%
PM growth 3Y-13.62%
PM growth 5Y-6.17%
GM growth 3Y3.79%
GM growth 5Y2.19%
HELE Yearly Profit, Operating, Gross MarginsHELE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HELE is destroying value.
Compared to 1 year ago, HELE has less shares outstanding
The number of shares outstanding for HELE has been reduced compared to 5 years ago.
The debt/assets ratio for HELE is higher compared to a year ago.
HELE Yearly Shares OutstandingHELE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
HELE Yearly Total Debt VS Total AssetsHELE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

HELE has an Altman-Z score of 1.69. This is a bad value and indicates that HELE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of HELE (1.69) is worse than 74.60% of its industry peers.
HELE has a debt to FCF ratio of 17.76. This is a negative value and a sign of low solvency as HELE would need 17.76 years to pay back of all of its debts.
The Debt to FCF ratio of HELE (17.76) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.94 indicates that HELE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.94, HELE is not doing good in the industry: 73.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 17.76
Altman-Z 1.69
ROIC/WACC0.82
WACC8.97%
HELE Yearly LT Debt VS Equity VS FCFHELE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

HELE has a Current Ratio of 1.71. This is a normal value and indicates that HELE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HELE (1.71) is worse than 69.84% of its industry peers.
A Quick Ratio of 0.74 indicates that HELE may have some problems paying its short term obligations.
HELE has a Quick ratio (0.74) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.74
HELE Yearly Current Assets VS Current LiabilitesHELE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

HELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.35%.
HELE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.99% yearly.
HELE shows a decrease in Revenue. In the last year, the revenue decreased by -5.69%.
The Revenue has been growing slightly by 2.24% on average over the past years.
EPS 1Y (TTM)-19.35%
EPS 3Y-16.48%
EPS 5Y-4.99%
EPS Q2Q%-51.24%
Revenue 1Y (TTM)-5.69%
Revenue growth 3Y-4.98%
Revenue growth 5Y2.24%
Sales Q2Q%-8.95%

3.2 Future

HELE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.58% yearly.
Based on estimates for the next years, HELE will show a small growth in Revenue. The Revenue will grow by 0.07% on average per year.
EPS Next Y-35.91%
EPS Next 2Y-15.96%
EPS Next 3Y-8.58%
EPS Next 5YN/A
Revenue Next Year-8.23%
Revenue Next 2Y-2.71%
Revenue Next 3Y0.07%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HELE Yearly Revenue VS EstimatesHELE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
HELE Yearly EPS VS EstimatesHELE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 3.31, the valuation of HELE can be described as very cheap.
96.83% of the companies in the same industry are more expensive than HELE, based on the Price/Earnings ratio.
HELE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.31.
The Price/Forward Earnings ratio is 3.91, which indicates a rather cheap valuation of HELE.
Based on the Price/Forward Earnings ratio, HELE is valued cheaply inside the industry as 98.41% of the companies are valued more expensively.
HELE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.85, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.31
Fwd PE 3.91
HELE Price Earnings VS Forward Price EarningsHELE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

HELE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HELE is cheaper than 80.95% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HELE indicates a rather cheap valuation: HELE is cheaper than 84.13% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.1
EV/EBITDA 5.93
HELE Per share dataHELE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

HELE's earnings are expected to decrease with -8.58% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.96%
EPS Next 3Y-8.58%

0

5. Dividend

5.1 Amount

No dividends for HELE!.
Industry RankSector Rank
Dividend Yield N/A

HELEN OF TROY LTD

NASDAQ:HELE (10/16/2025, 5:53:28 PM)

After market: 19.51 -0.36 (-1.81%)

19.87

+0.14 (+0.71%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-09 2025-10-09/bmo
Earnings (Next)01-07 2026-01-07/bmo
Inst Owners106.45%
Inst Owner Change-0.01%
Ins Owners1.34%
Ins Owner Change40.01%
Market Cap457.61M
Analysts74.55
Price Target28.05 (41.17%)
Short Float %14.48%
Short Ratio4.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.37%
Min EPS beat(2)-52.71%
Max EPS beat(2)9.97%
EPS beat(4)2
Avg EPS beat(4)-11.56%
Min EPS beat(4)-52.71%
Max EPS beat(4)9.97%
EPS beat(8)4
Avg EPS beat(8)-8.5%
EPS beat(12)8
Avg EPS beat(12)-3%
EPS beat(16)12
Avg EPS beat(16)0.85%
Revenue beat(2)1
Avg Revenue beat(2)-3.42%
Min Revenue beat(2)-7.92%
Max Revenue beat(2)1.08%
Revenue beat(4)1
Avg Revenue beat(4)-2.64%
Min Revenue beat(4)-7.92%
Max Revenue beat(4)1.08%
Revenue beat(8)3
Avg Revenue beat(8)-2.22%
Revenue beat(12)5
Avg Revenue beat(12)-1.29%
Revenue beat(16)8
Avg Revenue beat(16)0.94%
PT rev (1m)0%
PT rev (3m)-57.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-53.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.06%
Revenue NY rev (1m)-0.78%
Revenue NY rev (3m)-7.18%
Valuation
Industry RankSector Rank
PE 3.31
Fwd PE 3.91
P/S 0.25
P/FCF 9.1
P/OCF 5.02
P/B 0.49
P/tB N/A
EV/EBITDA 5.93
EPS(TTM)6
EY30.2%
EPS(NY)5.09
Fwd EY25.59%
FCF(TTM)2.18
FCFY10.99%
OCF(TTM)3.96
OCFY19.92%
SpS79.03
BVpS40.22
TBVpS-3.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.37%
ROE -71.13%
ROCE 9.1%
ROIC 7.34%
ROICexc 7.43%
ROICexgc 16.29%
OM 9.29%
PM (TTM) N/A
GM 47.3%
FCFM 2.76%
ROA(3y)4.94%
ROA(5y)6.79%
ROE(3y)9.09%
ROE(5y)12.93%
ROIC(3y)7.78%
ROIC(5y)9.49%
ROICexc(3y)7.81%
ROICexc(5y)9.62%
ROICexgc(3y)23.08%
ROICexgc(5y)29.38%
ROCE(3y)9.64%
ROCE(5y)11.77%
ROICexcg growth 3Y-15.74%
ROICexcg growth 5Y-12.1%
ROICexc growth 3Y-13.74%
ROICexc growth 5Y-11.08%
OM growth 3Y-3.04%
OM growth 5Y-2.95%
PM growth 3Y-13.62%
PM growth 5Y-6.17%
GM growth 3Y3.79%
GM growth 5Y2.19%
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 17.76
Debt/EBITDA 3.9
Cap/Depr 75.19%
Cap/Sales 2.25%
Interest Coverage 250
Cash Conversion 40.8%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 0.74
Altman-Z 1.69
F-Score3
WACC8.97%
ROIC/WACC0.82
Cap/Depr(3y)172.35%
Cap/Depr(5y)199.35%
Cap/Sales(3y)3.95%
Cap/Sales(5y)4.01%
Profit Quality(3y)83.41%
Profit Quality(5y)72.63%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3Y-16.48%
EPS 5Y-4.99%
EPS Q2Q%-51.24%
EPS Next Y-35.91%
EPS Next 2Y-15.96%
EPS Next 3Y-8.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.69%
Revenue growth 3Y-4.98%
Revenue growth 5Y2.24%
Sales Q2Q%-8.95%
Revenue Next Year-8.23%
Revenue Next 2Y-2.71%
Revenue Next 3Y0.07%
Revenue Next 5YN/A
EBIT growth 1Y-20.22%
EBIT growth 3Y-7.86%
EBIT growth 5Y-0.78%
EBIT Next Year-14.05%
EBIT Next 3Y0.54%
EBIT Next 5YN/A
FCF growth 1Y-85.97%
FCF growth 3Y9.8%
FCF growth 5Y-19.99%
OCF growth 1Y-79.35%
OCF growth 3Y-7.01%
OCF growth 5Y-16.04%